发明名称 Complementing cell lines
摘要 A packaging cell line that complements recombinant adenoviruses based on serotypes from subgroup B, preferably adenovirus type 35. The cell line may be derived from primary, diploid human cells that are transformed by adenovirus E1 sequences either operatively linked on one DNA molecule or located on two separate DNA molecules, the sequences being operatively linked to regulatory sequences enabling transcription and translation of encoded proteins. Also disclosed is a cell line derived from PER.C6® that expresses functional Ad35 E1B sequences. The Ad35-E1B sequences are driven by the E1B promoter or a heterologous promoter and terminated by a heterologous poly-adenylation signal. The cell lines are useful for producing recombinant adenoviruses designed for gene therapy and vaccination, and can also be used for producing human recombinant therapeutic proteins such as human growth factors and human antibodies. Also, the cell lines are useful for producing human viruses other than adenovirus such as influenza virus, herpes simplex virus, rotavirus, and measles virus.
申请公布号 US9228205(B2) 申请公布日期 2016.01.05
申请号 US201414335679 申请日期 2014.07.18
申请人 Crucell Holland B.V. 发明人 Vogels Ronald;Havenga Menzo Jans Emco;Mehtali Majid
分类号 C12N5/00;C12N15/86;C12N7/00;C12N7/02;C12N15/861 主分类号 C12N5/00
代理机构 TraskBritt, P.C. 代理人 TraskBritt, P.C.
主权项 1. An adenovirus packaging cell line permissive for replication of an E1A/E1B deficient adenovirus vector, wherein the cell line comprises an adenovirus E1A coding sequence operably linked to a first promoter and an adenovirus E1B coding sequence operably linked to a second promoter, separate from the first promoter, wherein both the first and second promoters lack substantial sequence identity with a native adenovirus E1A or E1B promoter, and wherein the adenovirus E1A coding sequence and the adenovirus E1B coding sequence are stably integrated into the cell line.
地址 Leiden NL